Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,155
Total Claims
$2.2M
Drug Cost
697
Beneficiaries
$3,228
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-88%
Opioid rate vs peers
0.3% vs 2.6% avg
+202%
Cost per patient vs peers
$3,228 vs $1,068 avg
+109%
Brand preference vs peers
18.8% vs 9.0% avg
Opioid Prescribing
0.3%
Opioid Rate
54
Opioid Claims
$380
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,145 claims · $1.9M
Generic: 13,582 claims · $292K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | 426 | $320K |
| Apixaban | 217 | $205K |
| Dapagliflozin Propanediol | 206 | $203K |
| Sitagliptin Phosphate | 167 | $182K |
| Insulin Glargine,hum.Rec.Anlog | 153 | $124K |
| Rivaroxaban | 108 | $120K |
| Insulin Aspart | 114 | $95K |
| Empagliflozin | 40 | $57K |
| Linaclotide | 66 | $51K |
| Sacubitril/Valsartan | 36 | $41K |
| Semaglutide | 42 | $41K |
| Fluticasone Propion/Salmeterol | 75 | $32K |
| Budesonide/Formoterol Fumarate | 68 | $29K |
| Insulin Detemir | 37 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 57 | $26K |
Prescribing Profile
Patient Profile
69
Avg Age
58%
Female
1.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data